Triple reuptake inhibitors reduce neuropathic pain

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-2149|19|3|322-333

ISSN： 1090-3801

Source： EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol.19, Iss.3, 2015-03, pp. : 322-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropathic Pain

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 6, Iss. 3, 2003-07 ,pp. : 193-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 1, 2018-01 ,pp. : 45-46

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focus on topiramate in neuropathic pain

By Dib Jean G  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1857-1861

Informa Healthcare

Access to resources Recommend Favorite

The assessment of neuropathic pain patients

By Haanpää Maija  

Pain Management, Vol. 3, Iss. 1, 2013-01 ,pp. : 59-65

Future Medicine

Access to resources Recommend Favorite

Neurosurgical Management of Neuropathic Pain

By  

Stereotactic and Functional Neurosurgery, Vol. 75, Iss. 2-3, 2001-12 ,pp. : 76-80

Karger

Access to resources Recommend Favorite